SARS-CoV-2:

Vanshika Rustagi1, Shradheya R R Gupta1, Chandni Talwar2

  • 1Department of Zoology, Deshbandhu College, University of Delhi, New Delhi, 110019, India.

Immunologic research
|December 18, 2024
PubMed
概括

COVID-19疫苗显著降低了疾病的严重程度和死亡率,其益处超过了罕见的不良事件,如血栓形成和吉兰-巴雷综合征 (GBS). mRNA疫苗技术提供了一种安全有效的替代方案.